ログイン
言語:

WEKO3

  • トップ
  • ランキング
To
lat lon distance
To

Field does not validate



インデックスリンク

インデックスツリー

メールアドレスを入力してください。

WEKO

One fine body…

WEKO

One fine body…

アイテム

  1. プロシーディングス

Carbon Ion Radiotherapy for Prostate Cancer

https://repo.qst.go.jp/records/54301
https://repo.qst.go.jp/records/54301
fd06c91c-7272-48a1-9a6f-d06e5780b29b
Item type 会議発表論文 / Conference Paper(1)
公開日 2011-11-21
タイトル
タイトル Carbon Ion Radiotherapy for Prostate Cancer
言語
言語 eng
資源タイプ
資源タイプ識別子 http://purl.org/coar/resource_type/c_5794
資源タイプ conference paper
アクセス権
アクセス権 metadata only access
アクセス権URI http://purl.org/coar/access_right/c_14cb
著者 Tsuji, Hiroshi

× Tsuji, Hiroshi

WEKO 554640

Tsuji, Hiroshi

Search repository
Okada, Tohru

× Okada, Tohru

WEKO 554641

Okada, Tohru

Search repository
Kamada, Tadashi

× Kamada, Tadashi

WEKO 554642

Kamada, Tadashi

Search repository
Tsujii, Hirohiko

× Tsujii, Hirohiko

WEKO 554643

Tsujii, Hirohiko

Search repository
辻 比呂志

× 辻 比呂志

WEKO 554644

en 辻 比呂志

Search repository
岡田 徹

× 岡田 徹

WEKO 554645

en 岡田 徹

Search repository
鎌田 正

× 鎌田 正

WEKO 554646

en 鎌田 正

Search repository
辻井 博彦

× 辻井 博彦

WEKO 554647

en 辻井 博彦

Search repository
抄録
内容記述タイプ Abstract
内容記述 Purpose: An up-to-date analysis of the results of hypofractionated conformal carbon ion radiotherapy (C-ion RT) for localized prostate cancer was performed to determine the normal tissue morbidity, biochemical relapse-free rate (bNED), and patient survival.
Methods and Materials: Nine hundred and three prostate cancer patients who received the C-ion RT that had been established by two prior dose-escalation studies were analyzed with regard to toxicity, survival, and bNED.
Results: Only 1 out of 818 patients followed up for at least 12 months developed grade 3 genitourinary toxicity, and no grade 3 or higher toxicities were observed in the rectum. The incidence of grade 2 rectum and GU morbidity were only 2.0% and 5.6%, respectively. The incidence of late toxicity in the patients treated with C-ion RT for 16 fractions was lower than that for patients who received 20 fractions. The overall bNED at 5 years was 90.9%, with only five local recurrences. The bNED of the 16-fraction C-ion RT was comparable to that of 20 fractions. The Gleason's score, T-stage, and initial PSA were significant prognostic factors for bNED, and the T-stage and initial PSA were also significant prognostic factors for the overall survival rate. C-ion RT with the established dose fractionation regimen yielded satisfactory bNED with very few local recurrences, and with minimal morbidity. Therefore, C-ion RT in 16 fractions could offer an even lower incidence of toxicities than 20 fractions, without any decrease in the biochemical control of the disease.
書誌情報 Proceedings of Japanease-European Joint Symposium on Ion Cancer Therapy and NIRS-KI Joint Symposium on Ion-Radiation Sciences, September 9 & 10-11, 2010 Karolinska University Hospital, Solna Stockholm, Sweden Organized by National Institute of Radiological Sciences, Japan and Karolinska Institute, Sweden

巻 NIRS-M, 号 235, p. 44-53, 発行日 2010
出版者
出版者 National Institute of Radiological Sciences
戻る
0
views
See details
Views

Versions

Ver.1 2023-05-15 23:02:33.390161
Show All versions

Share

Mendeley Twitter Facebook Print Addthis

Cite as

エクスポート

OAI-PMH
  • OAI-PMH JPCOAR 2.0
  • OAI-PMH JPCOAR 1.0
  • OAI-PMH DublinCore
  • OAI-PMH DDI
Other Formats
  • JSON
  • BIBTEX

Confirm


Powered by WEKO3


Powered by WEKO3